Lifesaving but Burdensome: Patient Perspectives on Methadone Treatment In Philadelphia

Background and Purpose: Methadone is a highly effective treatment for opioid use disorder (OUD), yet its delivery through highly regulated opioid treatment programs (OTPs) may create structural barriers that undermine treatment access and retention. While advocates have long pointed out the limitations of OTPs, the voices of people receiving methadone have been conspicuously absent from policy discussions and program design. These barriers may disproportionately affect individuals experiencing structural inequities, including poverty, housing instability, and limited access to supportive services. Understanding patient experiences is critical to informing more equitable, patient-centered models of OTP care and improving outcomes for people with OUD. This study examined patient experiences with methadone treatment in Philadelphia to identify barriers, facilitators, and patient-informed recommendations for improving OTP care delivery.

Methods: We conducted in-person, semi-structured interviews with people receiving methadone (n=36) for OUD in Philadelphia. Interviews explored participants' experiences with OTP policies (including take-home dose eligibility) and recommendations for improving care delivery. Interviews were audio-recorded, transcribed, de-identified, and analyzed using thematic analysis.

Results: Participants described methadone as both life-saving and burdensome, demonstrating tensions within the treatment system. For many, methadone functioned as a cornerstone for stability in their lives, with participants acknowledging its part in maintaining sobriety and daily functioning. Other participants noted that structural aspects of treatment, particularly daily dosing requirements, rigid schedules, and limited access to take-home doses, were burdensome and disruptive to employment, transportation, and housing stability. While some participants described supportive relationships with OTP staff, others reported feeling stigmatized, disrespected, or treated as “children.” Participants pointed out the need for additional supports beyond methadone treatment, including counseling and support in finding a job. Almost all participants recommended expanded take-home dose policies, though a small number noted that coming to the OTP daily was an important part of their sustained recovery.

Conclusions and Implications: Patients identify methadone as essential to their recovery while simultaneously experiencing structural and interpersonal barriers that threaten treatment retention. Expanding individualized take-home dose policies, training staff in patient-centered communication, and integrating employment and counseling services represent immediately actionable changes for policy and program design. Importantly, any policy reforms must preserve flexibility for patients who benefit from daily OTP attendance, underscoring the need for individualized, shared decision-making approaches to methadone care. These findings highlight the need for more flexible, equitable, and patient-centered models of care.